Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Israel Cañadas

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Gastroenterology|February 10, 2023
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator PhenotypeRossella Tricarico, Jozef Madzo, Gabrielle Scher, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Cancer Discovery|March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular PlasticityNavin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Immunology Research|June 9, 2022
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H Knelson, Elena V Ivanova, Mubin Tarannum, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Lab on a Chip|September 6, 2018
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockadeAmir R Aref, Marco Campisi, Elena Ivanova, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Nature Medicine|July 25, 2018
Tumor innate immunity primed by specific interferon-stimulated endogenous retrovirusesIsrael Cañadas, Rohit Thummalapalli, Jong Wook Kim, et al.
Gastroenterology|February 10, 2023
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator PhenotypeRossella Tricarico, Jozef Madzo, Gabrielle Scher, et al.
Nature Genetics|May 11, 2021
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependenceZhong Wu, Jin Zhou, Xiaoyang Zhang, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Cancer Discovery|March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular PlasticityNavin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Immunology Research|June 9, 2022
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H Knelson, Elena V Ivanova, Mubin Tarannum, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Pageof 4